Waylivra, Tecentriq and more accepted by SMC
admin 10th November 2020 Uncategorised 0Akcea’s Waylivra approved via ultra-orphan pathway More: Waylivra, Tecentriq and more accepted by SMC Source: News
read more
Akcea’s Waylivra approved via ultra-orphan pathway More: Waylivra, Tecentriq and more accepted by SMC Source: News
read moreDeal will help to support integrated health and care activities More: New NHS Digital deal set to improve data sharing between different organisations Source: News
read moreBTK inhibitor approved based on results from two phase III trials More: EU OK for AZ’s Calquence in CLL Source: News
read moreAfter Pfizer’s vaccine data, analysts say COVID19 drugmakers face questions about long-term sales prospects esagonowsky Mon, 11/09/2020 – 11:09 More: After Pfizer's vaccine data, analysts say COVID19 drugmakers face questions about long-term sales prospects Source: fierce
read moreFDA reputation takes another hit after scathing aducanumab advisory panel meeting bbulik Mon, 11/09/2020 – 10:50 More: FDA reputation takes another hit after scathing aducanumab advisory panel meeting Source: fierce
read morePfizer faces DOJ, SEC foreign bribery probes for China, Russia operations aliu Mon, 11/09/2020 – 09:55 More: Pfizer faces DOJ, SEC foreign bribery probes for China, Russia operations Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals